Cargando…
Technical Note: Patient dose from kilovoltage radiographs during motion‐synchronized treatments on Radixact(®)
PURPOSE: Synchrony is a motion management system available on the Radixact linear accelerator that utilizes kilovoltage (kV) radiographs to track target motion and synchronize the delivery of radiation with the motion. Proper management of this imaging dose requires accurate quantification. The purp...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756574/ https://www.ncbi.nlm.nih.gov/pubmed/32945563 http://dx.doi.org/10.1002/mp.14461 |
_version_ | 1783626572780011520 |
---|---|
author | Ferris, William S. Culberson, Wesley S. |
author_facet | Ferris, William S. Culberson, Wesley S. |
author_sort | Ferris, William S. |
collection | PubMed |
description | PURPOSE: Synchrony is a motion management system available on the Radixact linear accelerator that utilizes kilovoltage (kV) radiographs to track target motion and synchronize the delivery of radiation with the motion. Proper management of this imaging dose requires accurate quantification. The purpose of this work was to use Monte Carlo (MC) simulations to quantify organ‐specific patient doses from these images for various patient anatomies. METHODS: Point doses in water were measured per TG‐61 for three beam qualities commonly used on the Radixact. The point doses were used to benchmark a model of the imaging system built using the Monte Carlo N‐Particle (MCNP) transport code. Patient computed tomography (CT) datasets were obtained for 5 patients and 100 planar images were simulated for each patient. Patient dose was calculated using energy deposition mesh tallies. RESULTS: The MCNP model was able to accurately reproduce the measured point doses, with a median dose difference of less than 1%. The median dose (D(50%)) to soft tissue from 100 radiographs among the 5 patient cases ranged from 2.0 to 4.6 mGy. The max dose (D(1%)) to soft tissue ranged from 6.2 to 31.0 mGy and the max dose to bony structures ranged from 20.2 to 71.7 mGy. These doses can be scaled to estimate total patient dose throughout many fractions. CONCLUSIONS: Patient dose is largely dependent on imaging protocol, patient size, and treatment parameters such as fractionation and gantry period. Organ doses from 100 radiographs (an approximate number for one fraction) on the Radixact are slightly less than the doses from Tomo MVCT setup images. Careful selection of clinical protocols and planning parameters can be used to minimize risk from these images. |
format | Online Article Text |
id | pubmed-7756574 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77565742020-12-28 Technical Note: Patient dose from kilovoltage radiographs during motion‐synchronized treatments on Radixact(®) Ferris, William S. Culberson, Wesley S. Med Phys EMERGING IMAGING AND THERAPY MODALITIES PURPOSE: Synchrony is a motion management system available on the Radixact linear accelerator that utilizes kilovoltage (kV) radiographs to track target motion and synchronize the delivery of radiation with the motion. Proper management of this imaging dose requires accurate quantification. The purpose of this work was to use Monte Carlo (MC) simulations to quantify organ‐specific patient doses from these images for various patient anatomies. METHODS: Point doses in water were measured per TG‐61 for three beam qualities commonly used on the Radixact. The point doses were used to benchmark a model of the imaging system built using the Monte Carlo N‐Particle (MCNP) transport code. Patient computed tomography (CT) datasets were obtained for 5 patients and 100 planar images were simulated for each patient. Patient dose was calculated using energy deposition mesh tallies. RESULTS: The MCNP model was able to accurately reproduce the measured point doses, with a median dose difference of less than 1%. The median dose (D(50%)) to soft tissue from 100 radiographs among the 5 patient cases ranged from 2.0 to 4.6 mGy. The max dose (D(1%)) to soft tissue ranged from 6.2 to 31.0 mGy and the max dose to bony structures ranged from 20.2 to 71.7 mGy. These doses can be scaled to estimate total patient dose throughout many fractions. CONCLUSIONS: Patient dose is largely dependent on imaging protocol, patient size, and treatment parameters such as fractionation and gantry period. Organ doses from 100 radiographs (an approximate number for one fraction) on the Radixact are slightly less than the doses from Tomo MVCT setup images. Careful selection of clinical protocols and planning parameters can be used to minimize risk from these images. John Wiley and Sons Inc. 2020-10-14 2020-11 /pmc/articles/PMC7756574/ /pubmed/32945563 http://dx.doi.org/10.1002/mp.14461 Text en © 2020 The Authors. Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | EMERGING IMAGING AND THERAPY MODALITIES Ferris, William S. Culberson, Wesley S. Technical Note: Patient dose from kilovoltage radiographs during motion‐synchronized treatments on Radixact(®) |
title | Technical Note: Patient dose from kilovoltage radiographs during motion‐synchronized treatments on Radixact(®)
|
title_full | Technical Note: Patient dose from kilovoltage radiographs during motion‐synchronized treatments on Radixact(®)
|
title_fullStr | Technical Note: Patient dose from kilovoltage radiographs during motion‐synchronized treatments on Radixact(®)
|
title_full_unstemmed | Technical Note: Patient dose from kilovoltage radiographs during motion‐synchronized treatments on Radixact(®)
|
title_short | Technical Note: Patient dose from kilovoltage radiographs during motion‐synchronized treatments on Radixact(®)
|
title_sort | technical note: patient dose from kilovoltage radiographs during motion‐synchronized treatments on radixact(®) |
topic | EMERGING IMAGING AND THERAPY MODALITIES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756574/ https://www.ncbi.nlm.nih.gov/pubmed/32945563 http://dx.doi.org/10.1002/mp.14461 |
work_keys_str_mv | AT ferriswilliams technicalnotepatientdosefromkilovoltageradiographsduringmotionsynchronizedtreatmentsonradixact AT culbersonwesleys technicalnotepatientdosefromkilovoltageradiographsduringmotionsynchronizedtreatmentsonradixact |